Krystal Biotech Inc.

NASDAQ: KRYS · Real-Time Price · USD
150.42
0.09 (0.06%)
At close: Aug 15, 2025, 3:59 PM
147.27
-2.09%
After-hours: Aug 15, 2025, 07:11 PM EDT

Krystal Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
38.33M 35.73M 45.48M 27.18M 15.57M 932K 8.69M 80.75M -33.21M -45.3M -32.05M -29.85M -28.11M -49.97M -21.81M -15.59M -16.36M -15.81M
Depreciation & Amortization
1.54M 1.63M 1.55M 1.49M 1.99M 1.61M 1.51M 826K 1.04M 1.31M 1.09M 975K 976K 1.01M 784K 783K 666K 536K
Stock-Based Compensation
14.12M 13.48M 13.36M 13.32M 13.16M 9.3M 9.85M 8.31M 11.33M 10.44M 9.55M 9.06M 8.19M 6.43M 5.14M 3.67M 4.2M 2.31M
Other Working Capital
19.53M -19.53M 8.9M 15.84M 22.16M 12.24M 7.73M -8.83M -11.96M 8.7M 508K 504K -24.66M 27.72M -5.96M 3.43M 2.35M 1.52M
Other Non-Cash Items
-19.8M -1.34M -1.89M -1.32M 71M -238K 44.73M -1.92M -1.77M -1.41M -488K -36K -31K -135K 2.05M -1K 1K 1.49M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -46.3M -100M n/a n/a n/a n/a n/a n/a -2.05M 1K -1K n/a
Change in Working Capital
18.54M -18.54M -5.66M 18.2M -33.29M 6.3M -25.71M -9.19M -11.58M 8.81M -430K 164K -24.09M 27.16M -5.02M 3.89M 1.37M 1.82M
Operating Cash Flow
52.73M 30.97M 52.84M 58.86M -4.17M 15.89M -7.23M -21.23M -34.19M -26.16M -22.33M -19.69M -43.06M -15.49M -20.9M -7.25M -10.13M -9.65M
Capital Expenditures
-1.9M -6.2M -801K -1.05M -1.13M -1.26M -1.85M -1.78M -2.79M -5.38M -5.22M -14.06M -16.52M -17.19M -40.88M -20.99M -3.99M -2.47M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-113.9M -137.81M -143.47M -112.53M -113.4M -88.33M -82.91M -105.9M -174.39M -145.58M -104.07M -67.46M -84.5M -62.75M -106.65M -24.25M -59.56M n/a
Sales Maturities Of Investments
105.28M 88.81M 60.49M 79.25M 95.18M 63.62M 74.59M 112.87M 161.23M 154.52M 104.08M 66.77M 62.79M 24.04M 21M 8.07M 1.23M 1.73M
Other Investing Acitivies
n/a 435K n/a n/a n/a n/a n/a 100M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-10.53M -54.77M -83.78M -34.33M -19.35M -25.98M -10.16M 105.19M -15.96M 3.56M -5.21M -14.74M -38.22M -55.91M -126.54M -37.17M -62.32M -747K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.8M -12.47M 2.43M 3.37M 10.64M 10.58M n/a 13.51M n/a -749K n/a n/a n/a -649K n/a n/a n/a -7.96M
Financial Cash Flow
1.8M -12.47M 2.43M 3.37M 10.64M 10.58M 2.62M 13.39M 185.27M 1.47M 3.07M 2.12M 30.7M -542K 202.07M 1.51M -199K 144.3M
Net Cash Flow
45.06M -36.09M -29.1M 28.18M -13.22M 678K -14.91M 97.37M 135.13M -21.16M -24.51M -32.31M -50.58M -71.94M 54.63M -42.91M -72.64M 133.9M
Free Cash Flow
50.83M 24.77M 52.04M 57.81M -5.3M 14.63M -9.08M -23.01M -36.98M -31.54M -27.55M -33.74M -59.57M -32.68M -61.78M -28.25M -14.12M -12.13M